Lance Berman

3.1k total citations · 3 hit papers
30 papers, 2.1k citations indexed

About

Lance Berman is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Biomedical Engineering. According to data from OpenAlex, Lance Berman has authored 30 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 13 papers in Cardiology and Cardiovascular Medicine and 11 papers in Biomedical Engineering. Recurrent topics in Lance Berman's work include Potassium and Related Disorders (21 papers), Heart Failure Treatment and Management (12 papers) and Membrane-based Ion Separation Techniques (11 papers). Lance Berman is often cited by papers focused on Potassium and Related Disorders (21 papers), Heart Failure Treatment and Management (12 papers) and Membrane-based Ion Separation Techniques (11 papers). Lance Berman collaborates with scholars based in United States, United Kingdom and Spain. Lance Berman's co-authors include Dahlia Garza, George L. Bakris, Matthew R. Weir, David A. Bushinsky, Yuri Stasiv, Martha Mayo, Bertram Pitt, Paul M. Thompson, Steven E. Nissen and Magdi Ghali and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Lance Berman

28 papers receiving 2.0k citations

Hit Papers

Effect of Antihypertensive Agents on Cardiovascular Event... 2004 2026 2011 2018 2004 2014 2015 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure
    2004 769 citations Steven E. Nissen, E. Murat Tuzcu et al. JAMA profile →
  2. Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors
    2014 453 citations Matthew R. Weir, George L. Bakris et al. New England Journal of Medicine profile →
  3. Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease
    2015 312 citations George L. Bakris, Bertram Pitt et al. JAMA profile →

Peers

Lance Berman
Pieter Martens Belgium
Marco Trevisan Sweden
Jalaj Garg United States
James C. Fang United States
Valentina Carubelli Italy
Lenka Špinarová Czechia
Petra Nijst Belgium
Constantinos G. Missouris United Kingdom
Pitt Lim United Kingdom
Guillermo Cintrón United States
Pieter Martens Belgium
Lance Berman
Citations per year, relative to Lance Berman Lance Berman (= 1×) peers Pieter Martens

Countries citing papers authored by Lance Berman

Since Specialization
Citations

This map shows the geographic impact of Lance Berman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lance Berman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lance Berman more than expected).

Fields of papers citing papers by Lance Berman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lance Berman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lance Berman. The network helps show where Lance Berman may publish in the future.

Co-authorship network of co-authors of Lance Berman

This figure shows the co-authorship network connecting the top 25 collaborators of Lance Berman. A scholar is included among the top collaborators of Lance Berman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lance Berman. Lance Berman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cass, Lindsey, John Ayrton, Roger J. M. Brüggemann, et al.. (2025). In vitro and clinical data demonstrate negligible risk of drug–drug interactions with opelconazole, a novel inhaled antifungal agent. Journal of Antimicrobial Chemotherapy. 80(12). 3391–3400. 2 indexed citations
2.
3.
Bailón, Lucía, Beatriz Mothe, Lance Berman, & Christian Brander. (2020). Novel Approaches Towards a Functional Cure of HIV/AIDS. Drugs. 80(9). 859–868. 29 indexed citations
4.
Pitt, Bertram, David A. Bushinsky, Dalane W. Kitzman, et al.. (2018). Evaluation of an Individualized Dose Titration Regimen of Patiromer to Prevent Hyperkalaemia in Patients with Heart Failure and Chronic Kidney Disease. ESC Heart Failure. 5(3). 257–266. 39 indexed citations
5.
6.
Brandenburg, Vincent, Smeeta Sinha, José‐Vicente Torregrosa, et al.. (2018). FO020A PHASE 2 OPEN-LABEL SINGLE-ARM STUDY TO ASSESS THE EFFECT OF SNF472 ON WOUND HEALING IN CALCIPHYLAXIS (CALCIFIC UREMIC ARTERIOLOPATHY) PATIENTS. Nephrology Dialysis Transplantation. 33(suppl_1). i9–i9. 2 indexed citations
7.
Weir, Matthew R., Martha Mayo, Dahlia Garza, et al.. (2017). Effectiveness of patiromer in the treatment of hyperkalemia in chronic kidney disease patients with hypertension on diuretics. Journal of Hypertension. 35(Supplement 1). S57–S63. 18 indexed citations
8.
Zannad, Faı̈ez, Patrick Rossignol, Wendy Gattis Stough, et al.. (2016). New approaches to hyperkalemia in patients with indications for renin angiotensin aldosterone inhibitors: Considerations for trial design and regulatory approval. International Journal of Cardiology. 216. 46–51. 20 indexed citations
9.
Weir, Matthew R., George L. Bakris, Coleman Gross, et al.. (2016). Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors. Kidney International. 90(3). 696–704. 50 indexed citations
10.
Li, Lingyun, Stephen D. Harrison, M. Cope, et al.. (2016). Mechanism of Action and Pharmacology of Patiromer, a Nonabsorbed Cross-Linked Polymer That Lowers Serum Potassium Concentration in Patients With Hyperkalemia. Journal of Cardiovascular Pharmacology and Therapeutics. 21(5). 456–465. 89 indexed citations
11.
Epstein, Murray, Martha Mayo, Dahlia Garza, et al.. (2015). Abstract 14271: Patiromer Controls Hyperkalemia in Resistant Hypertensive Patients on RAASi, With Diabetic Kidney Disease. Circulation. 132(suppl_3). 6 indexed citations
12.
Pitt, Bertram, George L. Bakris, David A. Bushinsky, et al.. (2015). Effect of Patiromer on Reducing Serum Potassium and Preventing Recurrent Hyperkalaemia in Patients with Heart Failure and Chronic Kidney Disease on Raas Inhibitors. European Journal of Heart Failure. 17(10). 1057–1065. 117 indexed citations
13.
Bushinsky, David A., Gordon H. Williams, Bertram Pitt, et al.. (2015). Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia. Kidney International. 88(6). 1427–1433. 76 indexed citations
14.
Bakris, George L., Bertram Pitt, Matthew R. Weir, et al.. (2015). Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease. JAMA. 314(2). 151–151. 312 indexed citations breakdown →
15.
Pitt, Bertram, Dahlia Garza, Yuri Stasiv, et al.. (2015). 1-year safety and efficacy of patiromer for hyperkalemia in heart failure patients with chronic kidney disease on renin-angiotensin-aldosterone system inhibitors. Heart & Lung. 44(6). 549–550. 1 indexed citations
16.
Pitt, Bertram, Matthew R. Weir, David A. Bushinsky, et al.. (2015). Patiromer Reduces Serum K+ in Hyperkalemic Patients with HF and CKD on RAAS Inhibitors: Results from OPAL-HK and AMETHYST-DN. Journal of Cardiac Failure. 21(8). S107–S108. 5 indexed citations
17.
Weir, Matthew R., George L. Bakris, David A. Bushinsky, et al.. (2014). Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors. New England Journal of Medicine. 372(3). 211–221. 453 indexed citations breakdown →
18.
Chapman, Richard H., Allison Petrilla, Lance Berman, Joshua S. Benner, & Simon Tang. (2009). Are High-Risk Hypertensive Patients being Prescribed Concomitant Statin Therapy?. American Journal of Cardiovascular Drugs. 9(5). 299–308. 5 indexed citations
19.
Nissen, Steven E., E. Murat Tuzcu, Peter Libby, et al.. (2004). Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure. JAMA. 292(18). 2217–2217. 769 indexed citations breakdown →
20.
Berman, Lance, et al.. (1978). Analysis of some nuclear waste management options. Volume 1: Analysis and interpretation. STIN. 80. 12856. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pieter Martens Breakdown of academic impact, for papers by Marco Trevisan Breakdown of academic impact, for papers by Jalaj Garg Breakdown of academic impact, for papers by James C. Fang Breakdown of academic impact, for papers by Valentina Carubelli Breakdown of academic impact, for papers by Lenka Špinarová Breakdown of academic impact, for papers by Petra Nijst Breakdown of academic impact, for papers by Constantinos G. Missouris Breakdown of academic impact, for papers by Pitt Lim Breakdown of academic impact, for papers by Guillermo Cintrón
Rankless by CCL
2026